Trademark: 85069445
Word
PALACE
Status Date
Tuesday, February 15, 2011
Filing Date
Wednesday, June 23, 2010
Abandoned Date
Monday, February 14, 2011
42 Conducting clinical trials; conducting clinical trials on the safety and effectiveness of apremilast; conducting clinical trials on the safety and effectiveness of a drug for Psoriasis, Rheumatoid Arthritis and Cancer; conducting clinical trials on the safety and effectiveness of a drug directed to Prostate-specific antigen
Color is not claimed as a feature of the mark.
The mark consists of three diamond shapes to the left of the stylized wording PALACE.
Feb 15, 2011
Abandonment Notice Mailed - Express Abandonment
Feb 15, 2011
Abandonment - Express Mailed
Feb 14, 2011
Teas Express Abandonment Received
Aug 27, 2010
Notification Of Letter Of Suspension E-Mailed
Aug 27, 2010
Letter Of Suspension E-Mailed
Aug 27, 2010
Suspension Letter Written
Aug 19, 2010
Teas/Email Correspondence Entered
Aug 19, 2010
Correspondence Received In Law Office
Aug 19, 2010
Teas Response To Suspension Inquiry Received
Jul 16, 2010
Notification Of Letter Of Suspension E-Mailed
Jul 16, 2010
Letter Of Suspension E-Mailed
Jul 16, 2010
Suspension Letter Written
Jul 16, 2010
Teas/Email Correspondence Entered
Jul 14, 2010
Correspondence Received In Law Office
Jul 14, 2010
Teas Response To Office Action Received
Jul 14, 2010
Notification Of Non-Final Action E-Mailed
Jul 14, 2010
Non-Final Action E-Mailed
Jul 14, 2010
Non-Final Action Written
Jul 13, 2010
Assigned To Examiner
Jun 29, 2010
Notice Of Design Search Code Mailed
Jun 28, 2010
New Application Office Supplied Data Entered In Tram
Jun 26, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
